Giovanni Battista Migliori
Overview
Explore the profile of Giovanni Battista Migliori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
361
Citations
7977
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva D, Mello F, Galvao T, Dalcolmo M, Dos Santos A, Torres D, et al.
Arch Bronconeumol
. 2025 Mar;
PMID: 40055036
Introduction: The majority of the studies on pulmonary rehabilitation (PR) in post-tuberculosis lung disease (PTLD) were from a single center, had a low sample size and/or did not allow a...
2.
Picchianti-Diamanti A, Aiello A, De Lorenzo C, Migliori G, Goletti D
Front Immunol
. 2025 Feb;
16:1494283.
PMID: 39963138
Tuberculosis (TB) is the leading cause of death in the world from an infectious disease. Its etiologic agent, the (Mtb), is a slow-growing bacterium that has coexisted in humans for...
3.
Sabaghian T, Kharazmi A, Omidi F, Hajikhani B, Tehrani S, Mardani S, et al.
Immun Inflamm Dis
. 2025 Feb;
13(2):e70134.
PMID: 39898621
Introduction: As the COVID-19 pandemic transitions, understanding the intricate dynamics of the disease becomes paramount. This systematic review explores the role of antiphospholipid antibodies in COVID-19, focusing on their potential...
4.
Garcia-Prats A, Garcia-Cremades M, Cox V, Kredo T, Dunbar R, Schaaf H, et al.
Lancet Child Adolesc Health
. 2025 Jan;
9(2):100-111.
PMID: 39855750
Background: There are few data on the treatment of children and adolescents with multidrug-resistant (MDR) or rifampicin-resistant (RR) tuberculosis, especially with more recently available drugs and regimens. We aimed to...
5.
Sodeifian F, Kian N, Atefi A, Atefi A, Naserghandi A, Zangiabadian M, et al.
Respiration
. 2024 Dec;
:1-16.
PMID: 39733773
Introduction: Lung cancer is a leading cause of cancer-related deaths worldwide, with rising incidence in resource-limited settings. Research suggests an increased risk of lung cancer in individuals with a history...
6.
Visca D, Ardesi F, Zappa M, Grossi S, Pignatti P, Vanetti M, et al.
Ther Adv Respir Dis
. 2024 Dec;
18:17534666241304685.
PMID: 39686520
Background: Benralizumab is a monoclonal antibody treatment for severe eosinophilic asthma (SEA). Few studies investigated its role in airway inflammation and its correlation with lung function. Objectives: The aim of...
7.
Khelghati F, Rahmanian M, Eghbal E, Seghatoleslami Z, Goudarzi M, Keramatinia A, et al.
New Microbes New Infect
. 2024 Dec;
62:101533.
PMID: 39639969
Introduction: Tuberculosis (TB) risk associated with tumor necrosis factor-alpha (TNF-α) antagonist therapy in patients with autoimmune diseases is a significant concern. This study aims to evaluate the risk of TB...
8.
Akkerman O, Migliori G, Falzon D, Garcia-Basteiro A, Kanchar A, Konstantynovska O, et al.
Eur Respir J
. 2024 Nov;
64(6).
PMID: 39542460
No abstract available.
9.
Oraee S, Alinejadfard M, Golsorkh H, Sadeghian M, Fanaei M, Centis R, et al.
J Psychiatr Res
. 2024 Nov;
180:371-379.
PMID: 39522447
A large number of people worldwide grapple with Major Depressive Disorder (MDD), and a significant portion of them confront resistance to conventional antidepressant treatments. Esketamine, an innovative intervention, has garnered...
10.
Visca D, Ardesi F, Zappa M, Pignatti P, Grossi S, Vanetti M, et al.
Front Med (Lausanne)
. 2024 Oct;
11:1451625.
PMID: 39450103
Introduction: Asthma is a chronic inflammatory respiratory disease often associated with comorbidities. Among cardiovascular comorbidities, arterial hypertension seems to create an additional health burden in asthmatics. However, evidence on this...